Borongosam, Binasing M.

HRN: 16-92-81  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/17/2024
10/23/2024
IV
600
Q6
Herpes Zoster With Bacterial Infection
Waiting Final Action 
10/22/2024
CO-AMOXICLAV 625MG (TAB)
10/22/2024
10/29/2024
PO
625
BID
CAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: